Tate 2

Discussion Leaders and Presenters

As of 8/5/09:

  • Peter Barton Hutt Esq. Covington and Burling
  • Dr. Robert Hoyt, Department Head, Risk Management, University of Georgia
  • Scott Bass, Esq., Sidley Austin LLP
  • Robert Scales, Health Canada
  • Evelyn Bonnin, District Director, FDA
  • Kim Rice, Office of Criminal Investigations, FDA
  • Tor Graberg, Swedish Medical Products Agency
  • Phillip Campbell, Senior Compliance Officer, FDA
  • Malcolm Frazier, FDA, ORA
  • Rick Friedman, FDA, CDER
  • Edwin Rivera, FDA, CDER
  • Bill Frankos, FDA, CFSAN
  • Gregg Claycamp, FDA, CDER
  • Gary Buehler, FDA, CDER
  • Ilena, Pettit, FDA, ORA
  • Zena Kaufman, Abbott Labs
  • Martin Van Trieste, Amgen
  • Dale Carter, Huber Inc.
  • Bruce Little, Quality Management Systems
  • Dr. Sabine Kopp , WHO (invited)

(Additional presenters will be listed at a latter date)

Disclaimer -
All invited speakers have accepted but are on a “subject to availability” basis.